Fecal Microbiota Transplantation (FMT) for Clostridium Difficile (CEFTA)

University of Aarhus

Status: Enrolling

Conditions: Clostridium Difficile Infection

Treatments: Other: Faecal microbiota transplantation (FMT)

Study type: Observational

Funder types: Other

Identifiers

NCT03712722

1-16-02-15-16

Details and patient eligibility

About

Faecal microbiota transplantation (FMT) is used for recurrent Clostridium difficile infection (rCDI) as part of an quality improvement initiative and conducted within the framework of Center for Faecal Microbiota Transplantation at Aarhus University Hospital (CEFTA).

Full description

Patients are assessed, treated and monitored at Aarhus University Hospital (AUH) as an Integrated part of the project.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age 18 or higher
• documented recurrence of Clostridium difficile

Exclusion criteria

• none

Trial design

100 participants in 1 patient group

rCDI

Description:

Adult patients with recurrect Clostridium difficile infection

Treatment:

Other: Faecal microbiota transplantation (FMT)